24. September 2020 - Innovative medical device Rhenium-SCT® therapy for non-melanoma skin cancer of the gate-startup to be produced in Australia OncoBeta® GmbH, a commercial stage medical device company specialized in innovative epidermal radioisotope ... mehr erfahren
10. Februar 2020 - RadioMedix and OncoBeta today announced the execution of an exclusive distribution agreement for the next generation of W/Re-188 generators in the U.S. and Canada. The OncoBeta® Tungsten (Wolfram)-188/Rhenium-188 (W/Re-188) ... mehr erfahren
9. Dezember 2019 - OncoBeta® has recently been presented with the CV Magazine’s Corporate Excellence Award for the Most Compassionate Skin Cancer Therapy Provider in 2019. The Medical Device Company specialized in innovative epidermal radioisotope ... mehr erfahren
